1. Home
  2. AKTX vs GP Comparison

AKTX vs GP Comparison

Compare AKTX & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • GP
  • Stock Information
  • Founded
  • AKTX N/A
  • GP 2010
  • Country
  • AKTX United States
  • GP Canada
  • Employees
  • AKTX N/A
  • GP N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • AKTX Health Care
  • GP Consumer Discretionary
  • Exchange
  • AKTX Nasdaq
  • GP Nasdaq
  • Market Cap
  • AKTX 35.7M
  • GP 12.3M
  • IPO Year
  • AKTX N/A
  • GP 2020
  • Fundamental
  • Price
  • AKTX $1.08
  • GP $0.40
  • Analyst Decision
  • AKTX
  • GP Strong Buy
  • Analyst Count
  • AKTX 0
  • GP 2
  • Target Price
  • AKTX N/A
  • GP $2.33
  • AVG Volume (30 Days)
  • AKTX 22.7K
  • GP 80.8K
  • Earning Date
  • AKTX 08-18-2025
  • GP 08-13-2025
  • Dividend Yield
  • AKTX N/A
  • GP N/A
  • EPS Growth
  • AKTX N/A
  • GP N/A
  • EPS
  • AKTX N/A
  • GP N/A
  • Revenue
  • AKTX N/A
  • GP $20,656,035.00
  • Revenue This Year
  • AKTX N/A
  • GP N/A
  • Revenue Next Year
  • AKTX N/A
  • GP $94.25
  • P/E Ratio
  • AKTX N/A
  • GP N/A
  • Revenue Growth
  • AKTX N/A
  • GP N/A
  • 52 Week Low
  • AKTX $0.85
  • GP $0.36
  • 52 Week High
  • AKTX $4.40
  • GP $1.90
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 41.09
  • GP 45.05
  • Support Level
  • AKTX $1.10
  • GP $0.38
  • Resistance Level
  • AKTX $1.15
  • GP $0.44
  • Average True Range (ATR)
  • AKTX 0.03
  • GP 0.03
  • MACD
  • AKTX 0.00
  • GP 0.00
  • Stochastic Oscillator
  • AKTX 10.00
  • GP 50.26

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: